Clearside Biomedical Current Valuation vs. Shares Outstanding
| CLSD Stock | USD 1.08 0.06 5.88% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 1.02 | 0.9568 |
|
|
For Clearside Biomedical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Clearside Biomedical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Clearside Biomedical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Clearside Biomedical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Clearside Biomedical over time as well as its relative position and ranking within its peers.
Clearside |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearside Biomedical. If investors know Clearside will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearside Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.45) | Revenue Per Share 0.112 | Quarterly Revenue Growth (0.91) | Return On Assets (0.44) | Return On Equity (13.10) |
The market value of Clearside Biomedical is measured differently than its book value, which is the value of Clearside that is recorded on the company's balance sheet. Investors also form their own opinion of Clearside Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Clearside Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearside Biomedical's market value can be influenced by many factors that don't directly affect Clearside Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearside Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearside Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearside Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Clearside Biomedical Shares Outstanding vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Clearside Biomedical's current stock value. Our valuation model uses many indicators to compare Clearside Biomedical value to that of its competitors to determine the firm's financial worth. Clearside Biomedical is rated below average in current valuation category among its peers. It is rated below average in shares outstanding category among its peers creating about 1.28 of Shares Outstanding per Current Valuation. As of November 24, 2024, Common Stock Shares Outstanding is expected to decline to about 37.3 M. Comparative valuation analysis is a catch-all technique that is used if you cannot value Clearside Biomedical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Clearside Current Valuation vs. Competition
Clearside Biomedical is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 9.95 Billion. Clearside Biomedical maintains roughly 59.1 Million in current valuation contributing less than 1% to equities under Health Care industry.
Clearside Shares Outstanding vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Clearside Biomedical |
| = | 59.1 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Clearside Biomedical |
| = | 75.84 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Clearside Shares Outstanding Comparison
Clearside Biomedical is currently under evaluation in shares outstanding category among its peers.
Clearside Biomedical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Clearside Biomedical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Clearside Biomedical will eventually generate negative long term returns. The profitability progress is the general direction of Clearside Biomedical's change in net profit over the period of time. It can combine multiple indicators of Clearside Biomedical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -24.8 M | -26.1 M | |
| Income Before Tax | -32.5 M | -34.1 M | |
| Total Other Income Expense Net | -7.6 M | -7.3 M | |
| Net Loss | -32.5 M | -34.1 M | |
| Income Tax Expense | -100.9 K | -95.9 K | |
| Net Loss | -32.5 M | -34.1 M | |
| Net Loss | -37.9 M | -39.8 M | |
| Interest Income | 289.8 K | 257.6 K | |
| Non Operating Income Net Other | 769.4 K | 807.8 K | |
| Net Interest Income | -9.4 M | -8.9 M | |
| Change To Netincome | 5.7 M | 3.6 M | |
| Net Loss | (0.53) | (0.55) | |
| Income Quality | 0.56 | 0.59 | |
| Net Income Per E B T | 0.93 | 0.81 |
Clearside Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Clearside Biomedical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Clearside Biomedical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Clearside Biomedical's important profitability drivers and their relationship over time.
Use Clearside Biomedical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clearside Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearside Biomedical will appreciate offsetting losses from the drop in the long position's value.Clearside Biomedical Pair Trading
Clearside Biomedical Pair Trading Analysis
The ability to find closely correlated positions to Clearside Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clearside Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clearside Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clearside Biomedical to buy it.
The correlation of Clearside Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clearside Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clearside Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clearside Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Clearside Biomedical position
In addition to having Clearside Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run ISP Thematic Idea Now
ISP
Internet Service Providers (ISP) companies and IT providers specializing in internet technologies. The ISP theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ISP Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
To fully project Clearside Biomedical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Clearside Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Clearside Biomedical's income statement, its balance sheet, and the statement of cash flows.